Category: Professor Partnership Program

Articles written by undergraduates through our Professor Partnership Program. Learn more at www.sciworthy.com/ppp/

New study on immunotherapy for bone cancer A study in mice tested the effectiveness of an oncolytic, or cancer-destroying, virus called Delta-24-ACT. The treatment group developed tumors more slowly and experienced fewer severe side effects than the controls. Baby steps!

Posted on August 1, 2022August 1, 2022 by Francesca Pisanzio 244 views

A study in mice tested the effectiveness of an oncolytic, or cancer-destroying, virus called Delta-24-ACT. The treatment group developed…

A protein that lets the immune system “see” lung cancer With a frameshift mutation, every amino acid in the protein changes, creating a unique protein called a neoantigen. These neoantigens are easier for the immune system to recognize. Lung cancers with frameshift mutations are easier to treat.

Posted on July 28, 2022July 28, 2022 by Ava Devine 271 views

Personalized cancer treatment is on the rise. Cancer is not just one disease but thousands of different types and subtypes that each respond…

How the HPV virus causes cells to become cancer By analyzing cervical tissue of women who had hysterectomies, researchers found that the virus sets off a domino effect in the tissue that puts cell division into overdrive, increasing the risk that it will become cancer.

Posted on July 25, 2022July 22, 2022 by Kajal Reed 615 views

By analyzing cervical tissue of women who had hysterectomies, researchers found that the virus sets off a domino effect in the tissue that…

New therapy for non-small cell lung cancer Scientists at H. Lee Moffitt Cancer Center and Research Institute recently completed a Phase 1 trial for a new therapy for non-small cell lung cancer called TIL, which mobilizes special T-cells to go in and kill the cancer

Posted on July 21, 2022July 11, 2022 by Andrew Choy 369 views

Scientists at H. Lee Moffitt Cancer Center and Research Institute recently completed a Phase 1 trial for a new therapy for non-small cell…

Recent study suggests mono increases cancer risk The Epstein-Barr Virus, otherwise known as “mono,” appears to be linked to an increased likelihood of developing epithelial cancer later in life according to a recent study.

Posted on July 18, 2022July 11, 2022 by Anne Ebersold 321 views

The Epstein Barr virus (EBV) infects over 90% of the adult population in the world and causes the disease commonly known as “mono” or…

First two cancer patients treated with CAR T cells still in remission Their original killer T cells had turned into special helper T cells with two abilities: killing invading cells and helping other immune cells “see” invading cells.

Posted on July 14, 2022July 11, 2022 by Victoria Freitas 533 views

Their original killer T cells had turned into special helper T cells with two abilities: killing invading cells and helping other immune…

Do depression and anxiety affect cancer prognosis? Depression and anxiety are associated with breast cancer recurrence and mortality. However, anxiety is less associated with these outcomes compared to depression.

Posted on July 11, 2022July 11, 2022 by Lia Nocella 227 views

Depression and anxiety are associated with breast cancer recurrence and mortality. However, anxiety is less associated with these outcomes…

Using a modified herpes virus to treat skin cancer A modified herpes virus is being tested for its ability to treat skin cancer, and it is predicted to work best when the tumors are small.

Posted on July 7, 2022July 7, 2022 by Savannah Ziba 387 views

A modified herpes virus is being tested for its ability to treat skin cancer, and it is predicted to work best when the tumors are small.

Using the immune system to fight childhood brain and bone cancers A recent study in mice demonstrated that "immunotherapy," using a special cell called a B7-H3 CAR T Cell, was able to shrink bone and brain tumors and improve overall survival.

Posted on July 6, 2022July 6, 2022 by Caroline Elie 199 views

A recent study in mice demonstrated that "immunotherapy," using a special cell called a B7-H3 CAR T Cell, was able to shrink bone and brain…

The mRNA vaccine platform may also help cancer research Researchers tested, in cell culture and in mice, a version of the mRNA vaccine technology with an additive called resquimod, which made the treatment more effective than previous attempts to use mRNA vaccines to stimulate the body’s immune system to kill tumors.

Posted on June 30, 2022June 23, 2022 by Matthew Kowalczyk 275 views

Scientists have been developing vaccines to protect against disease for years. Most of these vaccines have been prophylactic, meaning they…

1
2
3
…
7